CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Millions		Total	Cumulative Effect, Period of Adoption, Adjustment	[3]	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	[3]	Treasury Stock	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	[3]	Accumulated Other Comprehensive (Loss) Income	Non-controlling Interests
Beginning Balance at Dec. 31, 2018		$ 889.0			$ 0.3	$ 460.2			$ 0.0	$ 453.9			$ (29.9)	$ 4.5
Beginning balance (shares) at Dec. 31, 2018					31,360,000
Increase (Decrease) in Stockholders' Equity
Net income		46.8								46.4				0.4
Other comprehensive income (loss)		(6.0)											(6.0)
Common stock issuance, net of equity issuance costs	[1]	286.3			$ 0.1	286.2
Common stock issuance, net of equity issuance costs (shares)	[1]				4,030,000.00
Share-based compensation expense		9.0				9.0
Common stock issued from share-based compensation plans		9.4				9.4
Common stock issued from share-based compensation plans (shares)					300,000
Common stock repurchases from share-based compensation plans		(2.0)				(2.0)
Common stock repurchases from share-based compensation plan (shares)					110,000
Dividend distribution to noncontrolling interest		(0.4)												(0.4)
Other		0.3												0.3
Ending Balance at Dec. 31, 2019		1,232.4			$ 0.4	762.8			0.0	500.3			(35.9)	4.8
Ending balance (shares) at Dec. 31, 2019					35,800,000
Increase (Decrease) in Stockholders' Equity
Net income		309.5								308.1				1.4
Other comprehensive income (loss)		38.3											38.3
Share-based compensation expense		8.9				8.9
Common stock issued from share-based compensation plans		11.0				11.0
Common stock issued from share-based compensation plans (shares)					420,000
Common stock repurchases from share-based compensation plans		(1.9)				(1.9)
Common stock repurchases from share-based compensation plan (shares)					(30,000.00)
Common stock repurchases	[2]	(19.3)							(19.3)
Other		0.4												0.4
Ending Balance at Dec. 31, 2020		$ 1,579.3	$ (26.2)		$ 0.4	780.8	$ (36.9)		(19.3)	808.4	$ 10.7		2.4	6.6
Ending balance (shares) at Dec. 31, 2020		36,185,829			36,190,000
Increase (Decrease) in Stockholders' Equity
Net income		$ 60.9								59.1				1.8
Other comprehensive income (loss)		(24.1)											(24.1)
Share-based compensation expense		11.2				11.2
Common stock issued from share-based compensation plans		$ 6.9				6.9
Common stock issued from share-based compensation plans (shares)		130,000			260,000
Common stock repurchases from share-based compensation plans		$ (6.4)				(6.4)
Common stock repurchases from share-based compensation plan (shares)					(40,000.00)
Acquisition of Earthly Labs Inc.		23.4				23.4
Acquisition of Earthly Labs Inc. (in shares)					140,000
Other		0.2												0.2
Ending Balance at Dec. 31, 2021		$ 1,625.2			$ 0.4	$ 779.0			$ (19.3)	$ 878.2			$ (21.7)	$ 8.6
Ending balance (shares) at Dec. 31, 2021		36,548,330			36,550,000

[1] Equity issuance costs were $9.5 during the year ended December 31, 2019.

[2] Includes $19.3 in shares repurchased through our share repurchase program. Refer to Note 2, “Significant Accounting Policies,” for further information.

[3] Refer to Note 2, “Significant Accounting Policies” for discussion regarding cumulative effect of change in accounting principle.